![](https://endpts.com/wp-content/uploads/2024/07/David-Earp-Circle-Pharma-feature.jpg)
David Earp, Circle Pharma CEO
Circle Pharma raises $54M as part of Series D while macrocycles heat up
Circle Pharma, a startup working on macrocycles for the “undruggable,” is seeking about $117 million for a Series D.
The company recently closed the first …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.